Vaccinogen
Biotechnology, Health Care, Therapeutics
Founded in 2007-01-01
Frederick, Maryland, United States
For Profit
About Vaccinogen
Vaccinogen manufactures vaccines and other immunotherapeutic products for cancers and infectious diseases. It operates as a biotechnology company that develops OncoVAX, an Active Specific Immunotherapy (ASI) vaccine which uses the patient's own cancer cells to block the return of colon cancer following surgery. The company was incorporated in 2007 and is based in Frederick, Maryland.
Company Metrics
- Employees: 11-50
- Monthly Visits: None
- Tech Stack: 13 active products
Financial Information
- Estimated Revenue: $10M to $50M
- Total Funding: 99051350 USD
- Last Funding: 80000000 USD (Post-IPO Equity)
- Funding Status: IPO
Technology Stack
Vaccinogen actively uses 13 products in their tech stack.
Market Presence
Industries: Biotechnology, Health Care, Therapeutics
Headquarters: Frederick, Maryland, United States